• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯 COVID-19 患者的流行病学和临床特征。

Epidemiological and clinical features of COVID-19 patients in Saudi Arabia.

机构信息

Global Center of Mass Gatherings Medicine, Ministry of Health, P. O. Box 8320, Riyadh 13314, Saudi Arabia.

Department of Emergency Medicine, College of Medicine, King Saud University, P.O. Box 7805, Riyadh 11472, Saudi Arabia.

出版信息

J Infect Public Health. 2021 Apr;14(4):437-443. doi: 10.1016/j.jiph.2021.01.003. Epub 2021 Jan 16.

DOI:10.1016/j.jiph.2021.01.003
PMID:33743364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7831680/
Abstract

BACKGROUND

The aim of this study is to describe the clinical and demographic characteristics of COVID-19 patients, and the risk factors associated with death in Saudi Arabia to serve as a reference to further understand this pandemic and to help in the future decisions and control of this global crisis.

METHODS

This multicenter, retrospective, observational, cross-sectional study was conducted on 240,474 patients with confirmed COVID-19 in Saudi Arabia. Data was collected retrospectively through the Health Electronic Surveillance Network at the Ministry of Health. Patients were classified based on their outcome as recovered, dead, or active with no definite outcome. We must specify the date period.

RESULTS

As of 20th of June 2020, 79.7% of COVID-19 cases were young and middle-aged, ranging between 20-59 years. There was evidently a difference in the sex ratio, where males constituted 71.7% of cases. The majority were non-Saudi nationals, representing 54.7% of cases. Furthermore, the contraction of COVID-19 was travel-related in 45.1% of cases. Signs and symptoms were reported in 63% of cases, the most common of which were fever; 85.2%, and cough; 85%. Deaths occurred more frequently in patients 40-49 years, 50-59 years, and 60-69 years, representing 19.2%, 27.9%, and 21.3% of deaths, respectively. Additionally, the case fatality rate (CFR) was higher in older age-groups, reaching 10.1% in those ≥80 years. Moreover, the CFR of males was higher than that of females, with 0.95% and 0.62%, respectively. As for nationality, Saudis had a CFR of 0.46% versus 1.19% in non-Saudis.

CONCLUSION

The total number of positive COVID-19 cases detected constitute 0.7% of the Saudi population to date. Older age, non-Saudi nationalities, being male, travelling outside Saudi Arabia, and the presence of symptoms, as opposed to being asymptomatic were considered risk factors and found to be significantly more associated with death in patients with COVID-19.

摘要

背景

本研究旨在描述 COVID-19 患者的临床和人口统计学特征,以及与沙特阿拉伯死亡相关的危险因素,为进一步了解这一大流行病提供参考,并有助于未来应对和控制这一全球危机。

方法

这是一项多中心、回顾性、观察性、横断面研究,纳入了沙特阿拉伯 240474 例确诊 COVID-19 患者。数据通过卫生部的电子健康监测网络进行回顾性收集。根据患者的结局(康复、死亡或无明确结局的活动病例)进行分类。我们必须指定日期范围。

结果

截至 2020 年 6 月 20 日,79.7%的 COVID-19 病例为中青年,年龄在 20-59 岁之间。性别比例明显不同,男性占病例的 71.7%。大多数患者为非沙特国籍,占病例的 54.7%。此外,45.1%的病例与旅行有关。63%的病例有症状和体征报告,最常见的是发热(85.2%)和咳嗽(85%)。40-49 岁、50-59 岁和 60-69 岁的患者死亡更为常见,分别占死亡人数的 19.2%、27.9%和 21.3%。此外,年龄较大的患者病死率(CFR)更高,≥80 岁的患者 CFR 为 10.1%。此外,男性的 CFR 高于女性,分别为 0.95%和 0.62%。就国籍而言,沙特人的 CFR 为 0.46%,而非沙特人的 CFR 为 1.19%。

结论

截至目前,沙特阿拉伯已检测出的 COVID-19 阳性病例总数占沙特人口的 0.7%。年龄较大、非沙特国籍、男性、出国旅行以及有症状而非无症状,被认为是 COVID-19 患者死亡的危险因素,且与死亡显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df52/7831680/ea4755233b9c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df52/7831680/492bf48ccf5c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df52/7831680/b3bab6b130cf/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df52/7831680/ea4755233b9c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df52/7831680/492bf48ccf5c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df52/7831680/b3bab6b130cf/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df52/7831680/ea4755233b9c/gr3_lrg.jpg

相似文献

1
Epidemiological and clinical features of COVID-19 patients in Saudi Arabia.沙特阿拉伯 COVID-19 患者的流行病学和临床特征。
J Infect Public Health. 2021 Apr;14(4):437-443. doi: 10.1016/j.jiph.2021.01.003. Epub 2021 Jan 16.
2
Clinical, epidemiological, and laboratory characteristics of mild-to-moderate COVID-19 patients in Saudi Arabia: an observational cohort study.沙特阿拉伯轻度至中度 COVID-19 患者的临床、流行病学和实验室特征:一项观察性队列研究。
Eur J Med Res. 2020 Nov 25;25(1):61. doi: 10.1186/s40001-020-00462-x.
3
Clinical characteristics of non-intensive care unit COVID-19 patients in Saudi Arabia: A descriptive cross-sectional study.沙特阿拉伯非重症监护病房 COVID-19 患者的临床特征:一项描述性横断面研究。
J Infect Public Health. 2020 Nov;13(11):1639-1644. doi: 10.1016/j.jiph.2020.09.003. Epub 2020 Sep 21.
4
CPMPARISON between COVID-19 and MERS demographic data in Saudi Arabia: a retrospective study.比较 COVID-19 和 MERS 在沙特阿拉伯的人口统计学数据:一项回顾性研究。
Libyan J Med. 2021 Dec;16(1):1910195. doi: 10.1080/19932820.2021.1910195.
5
Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study.沙特阿拉伯的 COVID-19 临床特征:一项全国性回顾性研究。
J Infect Public Health. 2020 Jul;13(7):920-925. doi: 10.1016/j.jiph.2020.05.026. Epub 2020 Jun 8.
6
Risk factors associated with worse outcomes in COVID-19: a retrospective study in Saudi Arabia.与 COVID-19 预后较差相关的风险因素:沙特阿拉伯的一项回顾性研究。
East Mediterr Health J. 2020 Nov 11;26(11):1371-1380. doi: 10.26719/emhj.20.130.
7
Epidemiology of COVID-19 in the Kingdom of Saudi Arabia: An Ecological Study.沙特阿拉伯王国2019冠状病毒病的流行病学:一项生态学研究。
Front Public Health. 2020 Sep 17;8:506. doi: 10.3389/fpubh.2020.00506. eCollection 2020.
8
Potential Cross-Reactive Immunity to COVID-19 Infection in Individuals With Laboratory-Confirmed MERS-CoV Infection: A National Retrospective Cohort Study From Saudi Arabia.在沙特阿拉伯进行的一项全国性回顾性队列研究:实验室确诊中东呼吸综合征冠状病毒感染个体对 COVID-19 感染的潜在交叉反应性免疫。
Front Immunol. 2021 Sep 17;12:727989. doi: 10.3389/fimmu.2021.727989. eCollection 2021.
9
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.在中东呼吸综合征冠状病毒流行地区住院的 COVID-19 患者的临床特征和转归。
J Epidemiol Glob Health. 2020 Sep;10(3):214-221. doi: 10.2991/jegh.k.200806.002.
10
Incidence of COVID-19 among returning travelers in quarantine facilities: A longitudinal study and lessons learned.隔离设施中返回旅行者的 COVID-19 发病率:一项纵向研究及经验教训。
Travel Med Infect Dis. 2020 Nov-Dec;38:101901. doi: 10.1016/j.tmaid.2020.101901. Epub 2020 Oct 10.

引用本文的文献

1
Detection of SARS-CoV-2 in nasopharyngeal swab samples from COVID-19 patients in Riyadh, Saudi Arabia: a PCR-based study.沙特阿拉伯利雅得新冠肺炎患者鼻咽拭子样本中SARS-CoV-2的检测:一项基于PCR的研究。
Virol J. 2025 Feb 19;22(1):43. doi: 10.1186/s12985-025-02655-4.
2
Laboratory biosafety: A visual analysis in the web of science database from 2000 to 2022: A review.实验室生物安全:对2000年至2022年科学网数据库的可视化分析:综述
Medicine (Baltimore). 2024 Dec 13;103(50):e40791. doi: 10.1097/MD.0000000000040791.
3
Clinical and epidemiological characteristics of COVID-19 mortality in Saudi Arabia: A retrospective multi-center study.
沙特阿拉伯新冠肺炎死亡病例的临床和流行病学特征:一项回顾性多中心研究。
J Family Med Prim Care. 2024 Oct;13(10):4270-4275. doi: 10.4103/jfmpc.jfmpc_128_24. Epub 2024 Oct 18.
4
Patient Characteristics and Clinical Outcomes During the 2020-2021 COVID-19 Wave: An Observational Study at a Tertiary Hospital in Saudi Arabia.2020 - 2021年新冠疫情期间的患者特征与临床结局:沙特阿拉伯一家三级医院的观察性研究
Cureus. 2024 Oct 9;16(10):e71119. doi: 10.7759/cureus.71119. eCollection 2024 Oct.
5
Assessment of COVID-19 Morbidity and Mortality Among Patients With Autoimmune Diseases at King Abdulaziz University Hospital.阿卜杜勒阿齐兹国王大学医院自身免疫性疾病患者中新冠病毒病的发病率和死亡率评估
Cureus. 2024 Jan 18;16(1):e52492. doi: 10.7759/cureus.52492. eCollection 2024 Jan.
6
Comparison of knowledge, perception and willingness to receive covid-19 vaccines among tertiary students in Osun State, Nigeria.尼日利亚奥孙州大学生对 COVID-19 疫苗的知识、认知和接种意愿比较。
Afr Health Sci. 2023 Sep;23(3):437-448. doi: 10.4314/ahs.v23i3.51.
7
The dynamics of SARS-CoV-2 infection in unvaccinated and vaccinated populations in Mumbai, India, between 28 December 2020 and 30 August 2021.2020 年 12 月 28 日至 2021 年 8 月 30 日期间,印度孟买未接种疫苗和已接种疫苗人群中 SARS-CoV-2 感染的动态。
Arch Virol. 2023 Jun 23;168(7):188. doi: 10.1007/s00705-023-05815-5.
8
The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid-19.静脉血栓栓塞和血液高乳酸血症的风险与 COVID-19 重症患者的死亡率增加有关。
Clin Respir J. 2023 Jun;17(6):580-588. doi: 10.1111/crj.13628. Epub 2023 May 5.
9
Acceptance towards COVID-19 vaccine among Qassim populations: A cross-sectional study.卡西姆人群对新冠疫苗的接受度:一项横断面研究。
J Family Med Prim Care. 2023 Feb;12(2):213-222. doi: 10.4103/jfmpc.jfmpc_457_22. Epub 2023 Feb 28.
10
Study of Coagulation Disorders and the Prevalence of Their Related Symptoms among COVID-19 Patients in Al-Jouf Region, Saudi Arabia during the COVID-19 Pandemic.沙特阿拉伯朱夫地区COVID-19大流行期间COVID-19患者凝血障碍及其相关症状的患病率研究。
Diagnostics (Basel). 2023 Mar 13;13(6):1085. doi: 10.3390/diagnostics13061085.